http://www.lls.org Podcast for those living with Non-Hodgkin Lymphoma (NHL). Sponsored by The Leukemia & Lymphoma Society. (c)2008 admin@lls.org (admin@lls.org) en-us Tue, 21 May 2013 17:27:25 GMT Hipcast RSS Feeder 1.25 Health & Fitness 60 http://lls.hipcast.com/albumart/1005.1369157245.jpg http://www.lls.org The Leukemia & Lymphoma Society Podcast for those living with Non-Hodgkin Lymphoma (NHL). Sponsored by The Leukemia & Lymphoma Society no non,hodgkin,lymphoma,nhl,cancer Samantha Mills admin@leukemia-lymphoma.org 04fdf3ee-2994-6741-e700-008610dd62eb Fri, 05 Apr 2013 20:38:30 GMT 00:40:24 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 1 no Blood Cancer Treatment - Making Informed Choices - Part 1 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3 c3d9e3ff-7cfe-2feb-761d-82b77ceeeb6c Fri, 05 Apr 2013 20:37:45 GMT 00:14:31 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 2 no Blood Cancer Treatment - Making Informed Choices - Part 2 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3 77e2fb37-b395-f5ad-d7b1-b0398f017062 Tue, 08 Jan 2013 20:31:06 GMT 00:21:32 The Leukemia & Lymphoma Society Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Update: ASCT for Lymphoma and Myeloma Part 2 no Update: ASCT for Lymphoma and Myeloma Part 2 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/19f43451-7f43-17a7-2828-d9db565fbbe9.mp3 f780d9ff-ee94-949b-d2d8-85b03a600da5 Tue, 08 Jan 2013 20:30:21 GMT 00:38:51 The Leukemia & Lymphoma Society Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications Update: ASCT for Lymphoma and Myeloma Part 1 no Update: ASCT for Lymphoma and Myeloma Part 1 Speakers: Jonathan W. Friedberg, MD, MMSc; Edward A. Stadtmauer, MD Topics: The role of autologous stem cell transplantation (ASCT) to treat patients with myeloma The role of ASCT to treat patients with lymphoma Side effects management and other quality of life issues for ASCT patients Key ASCT research topics The importance of patient-provider communications http://lls.hipcast.com/deluge/bc8da6b8-0758-e381-c23c-2518cc57d1cc.mp3 42026c5a-15a5-63c5-ffeb-cb1672e0151d Wed, 12 Dec 2012 15:44:36 GMT 01:35:55 The Leukemia & Lymphoma Society Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications NHL & CLL Diagnosis and Treatment Portuguese no NHL & CLL Diagnosis and Treatment Portuguese Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications http://lls.hipcast.com/deluge/2224bbe8-5059-e305-1a79-cf024e897847.mp3 aaac8027-f8a9-844e-456d-59c0373b08fc Wed, 12 Dec 2012 15:37:27 GMT 01:35:47 The Leukemia & Lymphoma Society Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications NHL & CLL Diagnosis and Treatment Spanish no NHL & CLL Diagnosis and Treatment Spanish Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications http://lls.hipcast.com/deluge/3d5da936-757a-4d91-053d-a8d40bbb874b.mp3 d8f851bd-5fc9-dd8f-a530-cbc5c4d02a25 Wed, 12 Dec 2012 15:31:24 GMT 00:21:53 The Leukemia & Lymphoma Society Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications NHL & CLL Diagnosis and Treatment Extended Q&A no NHL & CLL Diagnosis and Treatment Extended Q&A Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL, - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL, - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL, - The importance of clinical trials in improving patient outcomes, - Side effects management and other survivorship issues for patients, - The importance of patient-provider communications http://lls.hipcast.com/deluge/9ff83fdf-14dc-0ac0-d29e-a6bee029cb4b.mp3 8c14206d-4c67-829b-f07a-a75bfcbfcff5 Mon, 29 Oct 2012 14:49:25 GMT 00:30:08 The Leukemia & Lymphoma Society Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL; - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL; - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL; - The importance of clinical trials in improving patient outcomes; - Side effects management and other survivorship issues for patients; - The importance of patient-provider communications NHL & CLL Diagnosis and Treatment Update Q&A no NHL & CLL Diagnosis and Treatment Update Q&A Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL; - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL; - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL; - The importance of clinical trials in improving patient outcomes; - Side effects management and other survivorship issues for patients; - The importance of patient-provider communications http://lls.hipcast.com/deluge/7d1bc6d1-c0ff-6b04-3603-836ebd4cf654.mp3 e3fe5ddb-f5b3-65d9-6464-157b2adbc139 Mon, 29 Oct 2012 14:48:59 GMT 01:00:20 The Leukemia & Lymphoma Society Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL; - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL; - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL; - The importance of clinical trials in improving patient outcomes; - Side effects management and other survivorship issues for patients; - The importance of patient-provider communications NHL & CLL Diagnosis and Treatment Update Presentation no NHL & CLL Diagnosis and Treatment Update Presentation Speaker: Christopher R. Flowers, MD, MS; Topics Covered: - Signs and symptoms of indolent and aggressive NHL subtypes & CLL; - Diagnosis and treatment planning for indolent and aggressive NHL subtypes & CLL; - Current and emerging treatment options for patients with indolent or aggressive NHL subtypes or CLL; - The importance of clinical trials in improving patient outcomes; - Side effects management and other survivorship issues for patients; - The importance of patient-provider communications http://lls.hipcast.com/deluge/53bc76fa-74ca-70a4-0400-de804cbcdff9.mp3 59e53439-6af4-e960-b21c-3f6324b82ff0 Fri, 30 Sep 2011 15:36:34 GMT 00:32:09 The Leukemia & Lymphoma Society Topics Covered * Non-Hodgkin lymphoma (NHL) * Emerging treatments for NHL * The role of clinical trials in the improvement of NHL treatment * Quality of life issues in the treatment of patients with NHL NHL: Understanding Your Treatment Options Q&A no NHL: Understanding Your Treatment Options Q&A Topics Covered * Non-Hodgkin lymphoma (NHL) * Emerging treatments for NHL * The role of clinical trials in the improvement of NHL treatment * Quality of life issues in the treatment of patients with NHL http://lls.hipcast.com/deluge/c6a2d843-50b4-3bb1-09a4-935a90e1ca47.mp3 a33708bf-cb70-6f59-1bc3-129a8642618e Fri, 30 Sep 2011 15:36:01 GMT 00:28:34 The Leukemia & Lymphoma Society Topics Covered * Non-Hodgkin lymphoma (NHL) * Emerging treatments for NHL * The role of clinical trials in the improvement of NHL treatment * Quality of life issues in the treatment of patients with NHL NHL: Understanding Your Treatment Options Presentation no NHL: Understanding Your Treatment Options Presentation Topics Covered * Non-Hodgkin lymphoma (NHL) * Emerging treatments for NHL * The role of clinical trials in the improvement of NHL treatment * Quality of life issues in the treatment of patients with NHL http://lls.hipcast.com/deluge/8dc35eaf-3cba-aab8-1fc0-0f98d4c164c4.mp3 b1861708-24f2-268c-b894-e26ff11f67c8 Wed, 09 Feb 2011 16:12:23 GMT 01:15:56 The Leukemia & Lymphoma Society This program featured Andrew D. Zelenetz, MD, PhD, Chief, Lymphoma Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY NHL - What's New (ASH 2010 Conference) no NHL - What's New (ASH 2010 Conference) This program featured Andrew D. Zelenetz, MD, PhD, Chief, Lymphoma Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY http://lls.hipcast.com/deluge/4a4323f0-11bd-bf60-8e96-c6d283492e7d.mp3 e25c99bb-bfec-bf7f-da42-1afee44415b3 Mon, 22 Nov 2010 20:19:16 GMT 00:24:30 The Leukemia & Lymphoma Society Managing Mantle Cell Lymphoma - Part 2 (Q&A) November 4, 2010 This program featured Brad S. Kahl, MD, Associate Professor, Director Lymphoma Service, University of Wisconsin School of Medicine and Public Health, Associate Director for Clinical Research, UW Carbone Cancer Center, Madison, WI. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Millennium: The Takeda Oncology Company. Program Slides: http://www.lls.org/graphics/National/MantleCellprogramslidesFinal.pdf Managing Mantle Cell Lymphoma - Part 2 no Managing Mantle Cell Lymphoma - Part 2 Managing Mantle Cell Lymphoma - Part 2 (Q&A) November 4, 2010 This program featured Brad S. Kahl, MD, Associate Professor, Director Lymphoma Service, University of Wisconsin School of Medicine and Public Health, Associate Director for Clinical Research, UW Carbone Cancer Center, Madison, WI. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Millennium: The Takeda Oncology Company. Program Slides: http://www.lls.org/graphics/National/MantleCellprogramslidesFinal.pdf http://lls.hipcast.com/deluge/47acacfa-a5bc-1457-c4ca-81b9bcebe7be.mp3 dbf50d1d-23f2-7eee-f893-3eccb10155f3 Mon, 22 Nov 2010 20:17:54 GMT The Leukemia & Lymphoma Society Managing Mantle Cell Lymphoma - Part 1 (Presentation) November 4, 2010 This program featured Brad S. Kahl, MD, Associate Professor, Director Lymphoma Service, University of Wisconsin School of Medicine and Public Health, Associate Director for Clinical Research, UW Carbone Cancer Center, Madison, WI. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Millennium: The Takeda Oncology Company. Program Slides: http://www.lls.org/graphics/National/MantleCellprogramslidesFinal.pdf Managing Mantle Cell Lymphoma - Part 1 no http://www.leukemia-lymphoma.org/all_page?item_id=492628 4100a393-b6f5-cb39-2de3-8659d9867177 Wed, 03 Nov 2010 19:22:15 GMT 00:56:55 The Leukemia & Lymphoma Society Getting the Answers You Need: Fatigue and Other Cancer Treatment October 20, 2010 This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf Getting the Answers You Need: Fatigue and Other Cancer Treatment no Getting the Answers You Need: Fatigue and Other Cancer Treatment Getting the Answers You Need: Fatigue and Other Cancer Treatment October 20, 2010 This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3 445182a2-b477-ca96-cd68-3c81a9433b2f Thu, 28 Oct 2010 20:54:40 GMT 00:32:59 The Leukemia & Lymphoma Society Treatment News About Non-Hodgkin Lymphoma - Part 2 October 13, 2010: Part 2 - Q&A This program featured Owen A. O'Connor, MD, PhD, Professor of Medicine and Pharmacology, Deputy Director for Clinical Research and Cancer Treatment, Director, Division of Hematology and Medical Oncology, NYU Cancer Institute Department of Medicine, NYU Langone Medical Center, New York, NY. Treatment News About Non-Hodgkin Lymphoma - Part 2 no Treatment News About Non-Hodgkin Lymphoma - Part 2 Treatment News About Non-Hodgkin Lymphoma - Part 2 October 13, 2010: Part 2 - Q&A This program featured Owen A. O'Connor, MD, PhD, Professor of Medicine and Pharmacology, Deputy Director for Clinical Research and Cancer Treatment, Director, Division of Hematology and Medical Oncology, NYU Cancer Institute Department of Medicine, NYU Langone Medical Center, New York, NY. http://lls.hipcast.com/deluge/9e110f04-46b8-d7ad-de11-4efd8fa8403c.mp3 c2cf51d4-a9d3-6305-c5c2-80044dbe6aa0 Thu, 28 Oct 2010 20:54:03 GMT 00:45:27 The Leukemia & Lymphoma Society Treatment News About Non-Hodgkin Lymphoma - Part 1 October 13, 2010: Part 1 - Presentation This program featured Owen A. O'Connor, MD, PhD, Professor of Medicine and Pharmacology, Deputy Director for Clinical Research and Cancer Treatment, Director, Division of Hematology and Medical Oncology, NYU Cancer Institute Department of Medicine, NYU Langone Medical Center, New York, NY. Treatment News About Non-Hodgkin Lymphoma - Part 1 no Treatment News About Non-Hodgkin Lymphoma - Part 1 Treatment News About Non-Hodgkin Lymphoma - Part 1 October 13, 2010: Part 1 - Presentation This program featured Owen A. O'Connor, MD, PhD, Professor of Medicine and Pharmacology, Deputy Director for Clinical Research and Cancer Treatment, Director, Division of Hematology and Medical Oncology, NYU Cancer Institute Department of Medicine, NYU Langone Medical Center, New York, NY. http://lls.hipcast.com/deluge/d4636f0a-b0fb-c495-d500-eb63a94a8171.mp3 e8c92882-9d87-9a34-c72b-622df723465b Fri, 16 Jul 2010 18:19:58 GMT 00:51:40 The Leukemia & Lymphoma Society June 30, 2010 Navigating Employment and Insurance This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt A Young Adult Webcast no Navigating Employment and Insurance June 30, 2010 Navigating Employment and Insurance This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3 80616afa-f275-3282-2cd9-05172366565a Fri, 09 Jul 2010 16:00:44 GMT 00:59:54 The Leukemia & Lymphoma Society June 22, 2010 - Part 2 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. Partners in Progress: An Expert Panel Discussion - Part 2 no Partners in Progress: An Expert Panel Discussion - Part 2 June 22, 2010 - Part 2 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3 ed86f5ee-46ad-abda-3f98-9365eace8aac Fri, 09 Jul 2010 15:57:46 GMT 00:53:18 The Leukemia & Lymphoma Society June 22, 2010 - Part 1 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. Partners in Progress: An Expert Panel Discussion - Part 1 no Partners in Progress: An Expert Panel Discussion - Part 1 June 22, 2010 - Part 1 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3 3087442d-b79e-5ddb-f10d-51e52902b3d3 Fri, 09 Jul 2010 15:25:16 GMT 00:44:22 The Leukemia & Lymphoma Society June 15, 2010 - Part 2 This program featured John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech & Biogen Idec in collaboration with Abrale. NHL: A Guide to Treatment for the Newly Diagnosed - Part 2 no NHL: A Guide to Treatment for the Newly Diagnosed - Part 2 June 15, 2010 - Part 2 This program featured John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech & Biogen Idec in collaboration with Abrale. http://lls.hipcast.com/deluge/c418f710-1fee-7563-24b3-f492f71f0231.mp3 40c62cbf-ccd1-9c5c-077d-c8db7da95bfa Fri, 09 Jul 2010 15:24:06 GMT 00:42:01 The Leukemia & Lymphoma Society June 15, 2010 - Part 1 This program featured John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech & Biogen Idec in collaboration with Abrale. NHL: A Guide to Treatment for the Newly Diagnosed - Part 1 no NHL: A Guide to Treatment for the Newly Diagnosed - Part 1 June 15, 2010 - Part 1 This program featured John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech & Biogen Idec in collaboration with Abrale. http://lls.hipcast.com/deluge/773dd501-b803-c5e0-a294-20f43962a93f.mp3 72a41411-deeb-6914-543d-3782c0b72060 Tue, 05 Jan 2010 17:31:51 GMT 01:23:02 The Leukemia & Lymphoma Society December 17, 2009 NHL: Treatment Advances from the American Society of Hematology (ASH) Annual Meeting This program featured Jonathan W. Friedberg, MD, MMSc, Associate Professor of Medicine, Chief, Hematology/Oncology Division, Director, Hematological Malignancies Clinical Research, Wilmot Cancer Center, University of Rochester, Rochester, NY. NHL: Treatment Advances from ASH no NHL: Treatment Advances from ASH December 17, 2009 NHL: Treatment Advances from the American Society of Hematology (ASH) Annual Meeting This program featured Jonathan W. Friedberg, MD, MMSc, Associate Professor of Medicine, Chief, Hematology/Oncology Division, Director, Hematological Malignancies Clinical Research, Wilmot Cancer Center, University of Rochester, Rochester, NY. http://lls.hipcast.com/deluge/789157d1-f105-4525-b55d-7bd24e32fefc.mp3 dcf1c31c-101d-e6fc-c1c1-989479ddba85 Thu, 22 Oct 2009 15:35:21 GMT 01:01:48 The Leukemia & Lymphoma Society October 14, 2009 Treating Uncommon Lymphomas: Dialogue With an Expert on T-Cell, MALT, and Waldenström Macroglobulinemia This program featured Richard R. Furman, MD, Assistant Professor, Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Weill Medical College of Cornell University, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Allos Therapeutics, Inc. and Eisai Inc. Treating Uncommon Lymphomas no Treating Uncommon Lymphomas October 14, 2009 Treating Uncommon Lymphomas: Dialogue With an Expert on T-Cell, MALT, and Waldenström Macroglobulinemia This program featured Richard R. Furman, MD, Assistant Professor, Center for Lymphoma and Myeloma, Division of Hematology and Oncology, Weill Medical College of Cornell University, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Allos Therapeutics, Inc. and Eisai Inc. http://lls.hipcast.com/deluge/bc642a7f-2674-8a31-d9c7-0588e9173755.mp3 29e1178d-609f-679e-10e3-6b4bf4a9d5e6 Mon, 12 Oct 2009 14:44:10 GMT 00:36:27 The Leukemia & Lymphoma Society September 22, 2009 - Part 2 (Q&A) Emerging Therapies in NHL: Understanding Your Options This program featured Andrew D. Zelenetz, MD, PhD, Chief, Lymphoma Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech BioOncology and biogen idec. Part 2 of 2 no Emerging Therapies in NHL: Understanding Your Options September 22, 2009 - Part 2 (Q&A) Emerging Therapies in NHL: Understanding Your Options This program featured Andrew D. Zelenetz, MD, PhD, Chief, Lymphoma Service, Division of Hematology/Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Genentech BioOncology and biogen idec. http://lls.hipcast.com/deluge/b1362787-810f-91ba-4189-3e3e3e6647ec.mp3